Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Viroksavir by Traws Pharma for Pandemic Influenza: Likelihood of Approval
Viroksavir is under clinical development by Traws Pharma and currently in Phase I for Pandemic Influenza. According to GlobalData, Phase...
Viroksavir by Traws Pharma for Haemophilus influenzae Type A Infections: Likelihood of Approval
Viroksavir is under clinical development by Traws Pharma and currently in Phase I for Haemophilus influenzae Type A Infections. According...
Viroksavir by Traws Pharma for Haemophilus influenzae Type B Infections: Likelihood of Approval
Viroksavir is under clinical development by Traws Pharma and currently in Phase I for Haemophilus influenzae Type B Infections. According...
Viroksavir by Traws Pharma for Seasonal Influenza: Likelihood of Approval
Viroksavir is under clinical development by Traws Pharma and currently in Phase I for Seasonal Influenza. According to GlobalData, Phase...